KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Asset Writedowns and Impairment (2016 - 2026)

Staar Surgical (STAA) has disclosed Asset Writedowns and Impairment for 13 consecutive years, with $403000.0 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 124.26% year-over-year to $403000.0, compared with a TTM value of $3.7 million through Jan 2026, up 1181.12%, and an annual FY2026 reading of $3.7 million, up 1181.12% over the prior year.
  • Asset Writedowns and Impairment was $403000.0 for Q1 2026 at Staar Surgical, down from $5.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $5.1 million in Q3 2025 and bottomed at -$3.8 million in Q2 2025.
  • Average Asset Writedowns and Impairment over 5 years is $313562.5, with a median of $433500.0 recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment soared 639.39% in 2022, then tumbled 988.91% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$1.1 million in 2022, then tumbled by 59.98% to -$1.8 million in 2023, then increased by 6.21% to -$1.7 million in 2024, then skyrocketed by 405.78% to $5.1 million in 2025, then plummeted by 92.07% to $403000.0 in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for STAA at $403000.0 in Q1 2026, $5.1 million in Q3 2025, and -$3.8 million in Q2 2025.